Symbols / AIMD Stock $1.50 -3.23% Ainos, Inc.

Technology • Scientific & Technical Instruments • United States • NCM
AIMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Technology
Industry Scientific & Technical Instruments
CEO Mr. Chun-Hsien Tsai
Exch · Country NCM · United States
Market Cap 11.05M
Enterprise Value 24.18M
Income -13.94M
Sales 18.11K
FCF (ttm) 1.53M
Book/sh 0.93
Cash/sh 0.33
Employees 41
Insider 10d
IPO Jan 08, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E
PEG 0.93
P/S 609.95
P/B 1.61
P/C
EV/EBITDA -2.90
EV/Sales 1,335.35
Quick Ratio 0.45
Current Ratio 0.56
Debt/Eq 242.68
LT Debt/Eq
EPS (ttm) -2.83
EPS next Y
EPS Growth
Revenue Growth -99.80%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2007-03-26
Earnings (prior) 2007-03-26
ROA -33.84%
ROE -148.24%
ROIC
Gross Margin 79.15%
Oper. Margin -14,184.14%
Profit Margin 0.00%
Shs Outstand 7.36M
Shs Float 2.36M
Insider Own 64.13%
Instit Own 1.56%
Short Float 0.61%
Short Ratio 0.80
Short Interest 21.70K
52W High 4.50
vs 52W High -66.67%
52W Low 1.26
vs 52W Low 19.05%
Beta
Impl. Vol.
Rel Volume 1.36
Avg Volume 27.57K
Volume 37.55K
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $1.55
Price $1.50
Change -3.23%

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.50
Low
High
Mean
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-05 CHIANG YAO-CHUNG Director 129 $1.70 $219
2026-04-30 CHIANG YAO-CHUNG Director 300 $1.68 $511
2026-04-15 TSAI CHUN-HSIEN Chief Executive Officer 300,000 $1.61 $483,000
2026-04-15 TSAI CHUN-JUNG Director 330,000 $1.61 $531,300
2026-04-15 LEE TING CHUAN Director 570,000 $1.61 $917,700
2026-04-15 LEE TING CHUAN Director 570,000 $1.61 $917,700
2026-04-15 TSAI CHUN-HSIEN Chief Executive Officer 300,000 $1.61 $483,000
2026-04-15 TSAI CHUN-JUNG Director 330,000 $1.61 $531,300
2026-01-28 TAIWAN CARBON NANO TECHNOLOGY CORP Beneficial Owner of more than 10% of a Class of Security 46,000 $2.17 $99,806
2026-01-09 TAIWAN CARBON NANO TECHNOLOGY CORP Beneficial Owner of more than 10% of a Class of Security 1,281 $1.80 $2,336
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.12
+498.95%
0.02
-83.02%
0.12
-96.53%
3.52
Operating Revenue
0.12
+498.95%
0.02
-83.02%
0.12
-96.53%
3.52
Cost Of Revenue
0.02
-59.60%
0.05
-86.01%
0.38
-82.22%
2.11
Reconciled Cost Of Revenue
0.02
-59.60%
0.05
-86.01%
0.38
-82.22%
2.11
Gross Profit
0.10
+422.95%
-0.03
+87.44%
-0.25
-118.05%
1.41
Operating Expense
14.09
+2.06%
13.81
+6.61%
12.95
-15.79%
15.38
Research And Development
7.75
-7.89%
8.41
+14.99%
7.32
+6.89%
6.85
Selling General And Administration
6.34
+17.57%
5.40
-4.26%
5.64
-33.98%
8.54
Operating Income
-13.99
-1.08%
-13.84
-4.81%
-13.21
+5.51%
-13.98
Total Operating Income As Reported
-13.99
-1.08%
-13.84
-4.81%
-13.21
+5.51%
-13.98
EBITDA
-9.28
+1.76%
-9.44
-7.88%
-8.75
+4.00%
-9.12
Normalized EBITDA
-9.28
+1.76%
-9.44
-7.88%
-8.75
+4.00%
-9.12
Reconciled Depreciation
4.78
-0.45%
4.80
-1.42%
4.87
+0.78%
4.83
EBIT
-14.06
+1.32%
-14.25
-4.55%
-13.63
+2.35%
-13.95
Total Unusual Items
-0.43
Total Unusual Items Excluding Goodwill
-0.43
Net Income
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Pretax Income
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Non Operating Interest Income Expense
-0.71
-15.48%
-0.62
-327.53%
-0.14
-169.38%
-0.05
Interest Expense Non Operating
0.71
+15.48%
0.62
+327.53%
0.14
+169.38%
0.05
Net Interest Income
-0.71
-15.48%
-0.62
-327.53%
-0.14
-169.38%
-0.05
Interest Expense
0.71
+15.48%
0.62
+327.53%
0.14
+169.38%
0.05
Other Income Expense
-0.07
+83.22%
-0.40
+3.45%
-0.42
-1918.48%
0.02
Other Non Operating Income Expenses
-0.07
+83.22%
-0.40
+3.45%
-0.42
-1918.48%
0.02
Gain On Sale Of Security
-0.43
Tax Provision
0.00
+0.00%
0.00
+0.00%
0.00
0.00
Tax Rate For Calcs
0.00
-100.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Income From Continuing Operation Net Minority Interest
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Income From Continuing And Discontinued Operation
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Income Continuous Operations
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Normalized Income
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Net Income Common Stockholders
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Diluted EPS
-3.46
+55.75%
-7.82
+53.45%
-16.80
+34.63%
-25.70
Basic EPS
-3.46
+55.75%
-7.82
+53.45%
-16.80
+34.63%
-25.70
Basic Average Shares
4.27
+124.69%
1.90
+131.90%
0.82
+50.25%
0.55
Diluted Average Shares
4.27
+124.69%
1.90
+131.90%
0.82
+50.25%
0.55
Diluted NI Availto Com Stockholders
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Total Other Finance Cost
0.31
-41.34%
0.53
Line Item Trend 2025-12-31
Total Assets
20.87
Current Assets
1.14
Cash Cash Equivalents And Short Term Investments
0.42
Cash And Cash Equivalents
0.42
Receivables
0.00
Accounts Receivable
0.00
Inventory
0.30
Raw Materials
0.12
Work In Process
0.11
Finished Goods
0.07
Other Current Assets
0.43
Total Non Current Assets
19.73
Net PPE
0.34
Gross PPE
1.75
Accumulated Depreciation
-1.41
Machinery Furniture Equipment
1.75
Construction In Progress
Goodwill And Other Intangible Assets
19.23
Other Intangible Assets
19.23
Other Non Current Assets
0.16
Total Liabilities Net Minority Interest
13.31
Current Liabilities
1.08
Payables And Accrued Expenses
0.73
Payables
Current Accrued Expenses
0.73
Current Debt And Capital Lease Obligation
Current Debt
Other Current Borrowings
Current Deferred Liabilities
0.35
Current Deferred Revenue
0.35
Total Non Current Liabilities Net Minority Interest
12.23
Long Term Debt And Capital Lease Obligation
11.00
Long Term Debt
11.00
Long Term Capital Lease Obligation
Other Non Current Liabilities
1.23
Stockholders Equity
7.56
Common Stock Equity
7.56
Capital Stock
0.07
Common Stock
0.07
Preferred Stock
0.00
Share Issued
7.04
Ordinary Shares Number
5.88
Treasury Shares Number
1.16
Additional Paid In Capital
77.23
Retained Earnings
-67.52
Gains Losses Not Affecting Retained Earnings
-0.25
Treasury Stock
1.97
Total Equity Gross Minority Interest
7.56
Total Capitalization
18.56
Working Capital
0.06
Invested Capital
18.56
Total Debt
11.00
Net Debt
10.58
Capital Lease Obligations
Net Tangible Assets
-11.66
Tangible Book Value
-11.66
Current Notes Payable
Dueto Related Parties Current
Foreign Currency Translation Adjustments
-0.25
Other Equity Interest
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.61
+20.55%
-5.81
-23.72%
-4.69
-54.39%
-3.04
Cash Flow From Continuing Operating Activities
-4.61
+20.55%
-5.81
-23.72%
-4.69
-54.39%
-3.04
Net Income From Continuing Operations
-14.77
+0.62%
-14.86
-7.93%
-13.77
+1.69%
-14.01
Depreciation Amortization Depletion
4.78
-0.45%
4.80
-1.42%
4.87
+0.78%
4.83
Depreciation And Amortization
4.78
-0.45%
4.80
-1.42%
4.87
+0.78%
4.83
Other Non Cash Items
2.92
+635.04%
0.40
-83.93%
2.47
Stock Based Compensation
1.73
-51.23%
3.54
+217.83%
1.11
-82.64%
6.42
Asset Impairment Charge
0.00
-100.00%
0.52
0.00
Operating Gains Losses
-0.00
Unrealized Gain Loss On Investment Securities
0.00
-100.00%
0.28
+392.57%
-0.09
0.00
Gain Loss On Sale Of PPE
-0.00
0.00
0.00
Change In Working Capital
0.73
+1862.98%
0.04
-80.44%
0.19
+165.59%
-0.29
Change In Receivables
0.00
-91.48%
0.00
-99.80%
0.20
+199.77%
-0.20
Changes In Account Receivables
0.00
-91.48%
0.00
-99.80%
0.20
+199.77%
-0.20
Change In Inventory
-0.15
-736.86%
0.02
-89.25%
0.22
+137.26%
-0.60
Change In Prepaid Assets
Change In Payables And Accrued Expense
1.00
+1050.69%
-0.11
-1031.76%
-0.01
-103.94%
0.24
Change In Accrued Expense
1.00
+1050.69%
-0.11
-1031.76%
-0.01
-103.94%
0.24
Change In Payable
Change In Account Payable
Change In Other Working Capital
0.11
Change In Other Current Assets
-0.12
-203.92%
0.12
+152.94%
-0.22
-182.74%
0.27
Investing Cash Flow
-0.00
+98.23%
-0.13
-23.41%
-0.10
+83.89%
-0.63
Cash Flow From Continuing Investing Activities
-0.00
+98.23%
-0.13
-23.41%
-0.10
+83.89%
-0.63
Net PPE Purchase And Sale
-0.03
-62.02%
-0.02
+77.06%
-0.09
+85.33%
-0.63
Purchase Of PPE
-0.03
-62.02%
-0.02
+77.06%
-0.09
+85.33%
-0.63
Capital Expenditure
-0.03
-62.02%
-0.02
+77.06%
-0.09
+85.33%
-0.63
Net Intangibles Purchase And Sale
Purchase Of Intangibles
Net Other Investing Changes
0.03
+131.11%
-0.10
-1117.20%
-0.01
-334.32%
0.00
Financing Cash Flow
1.01
-87.43%
8.03
+63.00%
4.92
+27.86%
3.85
Cash Flow From Continuing Financing Activities
1.01
-87.43%
8.03
+63.00%
4.92
+27.86%
3.85
Net Issuance Payments Of Debt
-1.00
-112.31%
8.12
+52.87%
5.31
+156.64%
2.07
Issuance Of Debt
0.00
-100.00%
9.88
+64.58%
6.00
+172.73%
2.20
Repayment Of Debt
-1.00
+42.91%
-1.75
-155.35%
-0.69
-430.14%
-0.13
Long Term Debt Issuance
0.00
-100.00%
9.88
+64.58%
6.00
+172.73%
2.20
Long Term Debt Payments
-1.00
+42.91%
-1.75
-155.35%
-0.69
-430.14%
-0.13
Net Long Term Debt Issuance
-1.00
-112.31%
8.12
+52.87%
5.31
+156.64%
2.07
Short Term Debt Issuance
2.20
Short Term Debt Payments
-0.13
Net Short Term Debt Issuance
2.07
Net Common Stock Issuance
2.01
0.00
+100.00%
-0.00
-100.02%
1.78
Common Stock Payments
-0.00
0.00
+100.00%
-0.00
0.00
Repurchase Of Capital Stock
-0.00
0.00
+100.00%
-0.00
0.00
Proceeds From Stock Option Exercised
0.00
Net Other Financing Charges
-0.10
+75.00%
-0.39
-121.91%
1.78
Changes In Cash
-3.61
-272.47%
2.09
+1541.19%
0.13
-29.13%
0.18
Effect Of Exchange Rate Changes
0.13
+256.54%
-0.08
+10.84%
-0.10
-22.04%
-0.08
Beginning Cash Position
3.89
+106.45%
1.89
+1.74%
1.85
+5.82%
1.75
End Cash Position
0.42
-89.28%
3.89
+106.45%
1.89
+1.74%
1.85
Free Cash Flow
-4.65
+20.25%
-5.83
-21.76%
-4.79
-30.29%
-3.67
Interest Paid Supplemental Data
0.00
-99.85%
0.02
+28.25%
0.02
-60.94%
0.04
Income Tax Paid Supplemental Data
0.00
+0.00%
0.00
+0.00%
0.00
0.00
Common Stock Issuance
2.01
0.00
0.00
-100.00%
1.78
Issuance Of Capital Stock
2.01
0.00
0.00
-100.00%
1.78
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category